Non-Executive Director Retirement

Genus (LSE: GNS), a leading global animal genetics company, announces that Professor Jason Chin has informed the Company of his intention to step down from the Genus Board, effective from the end of May 2025, as he will be taking on a significant new role as Founding Director of the Generative Biology Institute at the Ellison Institute of Technology. Professor Chin has served as a Non-Executive Director, Chairman of the Company's Scientific Advisory Board and advisor to the Company's Global Portfolio Steering Committee for four years. Upon stepping down from the Board, Professor Chin will remain a member of the Scientific Advisory Board.

The Board has initiated a comprehensive search for Professor Chin's successor and will provide an update once this process has concluded.

Commenting on the changes, Iain Ferguson, Chairman of Genus, said:

"Over the last four years Professor Jason Chin has provided the Company with significant scientific expertise, guidance and insight as we progress our innovative science platforms. We wish him well in his new role."

Charles Ryland; Toto Berger; Sophie Wills; Verity Parker

This announcement is available on the Genus website www.genusplc.com

Regulatory Notes

This announcement is made in accordance with Listing Rule 6.4.6R.